Intestinal Barrier Function in Health and Disease-Any Role of SARS-CoV-2?

被引:35
作者
Sharma, Lakshya [1 ]
Riva, Antonio [1 ,2 ]
机构
[1] Kings Coll London, Fac Life Sci & Med, London SE1 1UL, England
[2] Fdn Liver Res, Inst Hepatol, London SE5 9NT, England
关键词
gastrointestinal; COVID-19; SARS-CoV-2; microbiota; gut barrier; gut permeability; gut-liver axis; immune; FMT; probiotics; FATTY LIVER-DISEASE; POSTOPERATIVE INFECTIOUS COMPLICATIONS; INTERNATIONAL SCIENTIFIC ASSOCIATION; PERIOPERATIVE PROBIOTIC TREATMENT; INFLAMMATORY-BOWEL-DISEASE; COLORECTAL-CANCER SURGERY; TIGHTENS LEAKY GUT; INVARIANT T-CELLS; GASTROINTESTINAL SYMPTOMS; EPITHELIAL BARRIER;
D O I
10.3390/microorganisms8111744
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Alterations in the structure and function of the intestinal barrier play a role in the pathogenesis of a multitude of diseases. During the recent and ongoing coronavirus disease (COVID-19) pandemic, it has become clear that the gastrointestinal system and the gut barrier may be affected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, and disruption of barrier functions or intestinal microbial dysbiosis may have an impact on the progression and severity of this new disease. In this review, we aim to provide an overview of current evidence on the involvement of gut alterations in human disease including COVID-19, with a prospective outlook on supportive therapeutic strategies that may be investigated to rescue intestinal barrier functions and possibly facilitate clinical improvement in these patients.
引用
收藏
页码:1 / 27
页数:26
相关论文
共 193 条
  • [1] Gastrointestinal and Liver Manifestations of COVID-19
    Agarwal, Amol
    Chen, Alan
    Ravindran, Nishal
    To, Chau
    Thuluvath, Paul J.
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 10 (03) : 263 - 265
  • [2] Probiotics and COVID-19: is there any link?
    Akour, A.
    [J]. LETTERS IN APPLIED MICROBIOLOGY, 2020, 71 (03) : 229 - 234
  • [3] Gut-lung axis and dysbiosis in COVID-19
    Aktas, Busra
    Aslim, Belma
    [J]. TURKISH JOURNAL OF BIOLOGY, 2020, 44 (03) : 265 - 272
  • [4] The gut-liver axis in liver disease: Pathophysiological basis for therapy
    Albillos, Agustin
    de Gottardi, Andrea
    Rescigno, Maria
    [J]. JOURNAL OF HEPATOLOGY, 2020, 72 (03) : 558 - 577
  • [5] Probiotics and Coronavirus disease 2019: think about the link
    Angurana, Suresh Kumar
    Bansal, Arun
    [J]. BRITISH JOURNAL OF NUTRITION, 2021, 126 (10) : 1564 - 1570
  • [6] Microbes, metabolites, and the gut-lung axis
    Anh Thu Dang
    Marsland, Benjamin J.
    [J]. MUCOSAL IMMUNOLOGY, 2019, 12 (04) : 843 - 850
  • [7] [Anonymous], 2006, Probiotics in food: health and nutritional properties and guidelines for evaluation
  • [8] [Anonymous], 2018, J HEPATOL
  • [9] [Anonymous], 2020, COLORECTAL DIS, DOI DOI 10.1111/codi.15138
  • [10] Alterations in intestinal permeability
    Arrieta, M. C.
    Bistritz, L.
    Meddings, J. B.
    [J]. GUT, 2006, 55 (10) : 1512 - 1520